Viewing StudyNCT06365970



Ignite Creation Date: 2024-05-06 @ 8:23 PM
Last Modification Date: 2024-10-26 @ 3:26 PM
Study NCT ID: NCT06365970
Status: NOT_YET_RECRUITING
Last Update Posted: 2024-05-06
First Post: 2024-03-29

Brief Title: Niraparib and Dostarlimab for Patients With MMR-DMSI-H Colorectal Cancers
Sponsor: Ibrahim Halil Sahin
Organization: University of Pittsburgh

Conditions & Keywords Data

Conditions:
Name
MMR-DMSI-H Colorectal Cancers
Keywords:
Name View
PARP inhibitor View
MRE11 deficiency View
Immune checkpoint inhibitor View
Homologous recombination defect View
HRD View
MSI-HMMR-D Colorectal cancer View
Niraparib View
Dostarlimab View